[Status of clinical experiments with the thymoleptic-anxiolytic, dimethacrine].
D000166:Acridines / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D000639:Amitriptyline / Q000627:therapeutic use; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D003990:Dibenzoxepins / Q000627:therapeutic use; D004285:Dogs; D006207:Half-Life; D006321:Heart / Q000187:drug effects; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D014316:Tritium
D000166:Acridines; D000928:Antidepressive Agents; D003990:Dibenzoxepins; D010919:Placebos; D014316:Tritium; D000639:Amitriptyline; D007099:Imipramine
Stand der klinischen Erfahrungen mit dem Thymoleptikum-Anxiolytikum Dimetacrin.